Company Overview and News


Add OCC
to your dashboard

Headline News

Orthocell granted European patent for tissue repair technology

2017-01-31 proactiveinvestors.com.au
Orthocell (ASX:OCC) has received a European patent for its pipeline ‘Cell Factory’ technology, which produces tissue specific growth factors and bioactive proteins to enhance tissue repair.

Orthocell Ltd set to trial cell therapy injection for tennis elbow

2016-07-12 proactiveinvestors.com.au
Orthocell Ltd (ASX:OCC) will move ahead with a study comparing surgery for severe tennis elbow to Orthocell’s cell therapy Ortho-ATI injection, after receiving ethics approval to conduct the study. The primary endpoint of the study is to show that a single non-invasive treatment of Ortho-ATI is superior or equivalent to the more costly and invasive surgical intervention for the repair of severe, treatment-resistant Lateral Epicondylitis.

Appendix 4C - quarterly

2016-04-29 asx.com.au

Half Yearly Report and Accounts

2016-02-26 asx.com.au

Appendix 3B

2016-02-26 asx.com.au

Appendix 4C - quarterly

2016-01-29 asx.com.au

Results of Meeting

2016-01-27 asx.com.au

Investor Presentation

2015-11-30 asx.com.au

Results of Meeting

2015-11-27 asx.com.au

Change in substantial holding MC

2015-11-25 asx.com.au